Lv3
228 积分 2024-07-07 加入
Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder
5小时前
待确认
Anti-CD7 CAR T cells for T-ALL: impressive early-stage efficacy
20天前
已完结
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
20天前
已完结
Emerging trends in clinical allogeneic CAR cell therapy
20天前
已完结
Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms
1个月前
已完结
Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis
1个月前
已完结
Characteristics of second primary malignancies following bispecific antibodies therapy
1个月前
已完结
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study
1个月前
已完结
Brexucabtagene autoleucel (Brexu-cel) as consolidation treatment in adults with B-cell acute lymphoblastic leukemia
2个月前
已关闭
Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus
2个月前
已完结
Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database
皖公网安备34019202002308
